Clinical investigation of medicinal products indicated for generalised anxiety disorder

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/4284/2002
Effective from01/07/2005
KeywordsAnxiety, general anxiety disorder (GAD)
DescriptionThis document provides guidance on the evaluation of new medicinal products intended for the use in the treatment of generalised anxiety disorder.

Related content

How helpful is this page?

Average rating:

 Based on 20 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
4 ratings

Tell us more